Cargando…

LAPTM4B promotes the progression of nasopharyngeal cancer

Lysosomal protein transmembrane 4 beta (LAPTM4B) is a protein that contains four transmembrane domains. The impact of LAPTM4B on the malignancy of nasopharyngeal carcinoma (NPC) remains unclear. In the present study, we aimed to investigate the role of LAPTM4B in NPC. NPC tissue samples were used to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Qun, Luo, Hongtao, Zhang, Ming, Gao, Liying, Zhao, Fengju
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112566/ https://www.ncbi.nlm.nih.gov/pubmed/32651973 http://dx.doi.org/10.17305/bjbms.2020.4738

Ejemplares similares

LAPTM4B promotes the progression of bladder cancer by stimulating cell proliferation and invasion
por: Yin, Yanhua, et al.
Publicado: (2021)

LAPTM4B knockdown increases the radiosensitivity of EGFR-overexpressing radioresistant nasopharyngeal cancer cells by inhibiting autophagy
por: Chu, Chu, et al.
Publicado: (2019)

Autophagy-related gene LAPTM4B promotes the progression of renal clear cell carcinoma and is associated with immunity
por: Wang, He, et al.
Publicado: (2023)

LAPTM4B Allele *2 Is Associated with Breast Cancer Susceptibility and Prognosis
por: Li, Xiaoyan, et al.
Publicado: (2012)

Transport of LAPTM5 to lysosomes requires association with the ubiquitin ligase Nedd4, but not LAPTM5 ubiquitination
por: Pak, Youngshil, et al.
Publicado: (2006)

LAPTM4B: an oncogene in various solid tumors and its functions
por: Meng, Y, et al.
Publicado: (2016)

Serum LAPTM4B as a Potential Diagnostic and Prognostic Biomarker for Breast Cancer
por: Wang, Lu, et al.
Publicado: (2022)

Increased levels of LAPTM4B, VEGF and survivin are correlated with tumor progression and poor prognosis in breast cancer patients
por: Li, Sha, et al.
Publicado: (2017)

LAPTM4B facilitates tumor growth and induces autophagy in hepatocellular carcinoma
por: Wang, Fei, et al.
Publicado: (2019)

Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer
por: Li, Yang, et al.
Publicado: (2010)

Prognostic Values of LAPTM4B-35 in Human Cancer: A Meta-analysis
por: Zhou, Linghui, et al.
Publicado: (2018)

LAPTM4B Allele *2 Is a Marker of Poor Prognosis for Gallbladder Carcinoma
por: Zhai, Guojun, et al.
Publicado: (2012)

Overexpression of LAPTM4B-35: A Novel Marker of Poor Prognosis of Prostate Cancer
por: Zhang, Hongtuan, et al.
Publicado: (2014)

LAPTM4B-YAP loop feedback amplification enhances the stemness of hepatocellular carcinoma
por: Liao, Jianping, et al.
Publicado: (2023)

LAPTM4B-35 protein is a weak tumor-associated antigen candidate
por: SHI, GUILAN, et al.
Publicado: (2014)

LAPTM4B Gene Expression and Polymorphism as Diagnostic Markers of Breast Cancer in Egyptian Patients
por: Shaker, Olfat, et al.
Publicado: (2015)

AP4 positively regulates LAPTM4B to promote hepatocellular carcinoma growth and metastasis, while reducing chemotherapy sensitivity
por: Meng, Yue, et al.
Publicado: (2018)

Relationship Between LAPTM4B Gene Polymorphism and Susceptibility of Malignant Melanoma in Chinese Patients
por: Zhang, Meng, et al.
Publicado: (2014)

Vpr counteracts the restriction of LAPTM5 to promote HIV-1 infection in macrophages
por: Zhao, Li, et al.
Publicado: (2021)

LAPTM4B*2 allele is associated with the development of papillary thyroid carcinoma in Chinese women
por: Meng, Yue, et al.
Publicado: (2017)

LAPTM4B polymorphism increases susceptibility to multiple cancers in Chinese populations: a meta-analysis
por: Mo, Cuiju, et al.
Publicado: (2014)

LAPTM4B gene polymorphism augments the risk of cancer: Evidence from an updated meta‐analysis
por: Hashemi, Mohammad, et al.
Publicado: (2018)

Down-regulation of LAPTM5 in human cancer cells
por: Nuylan, Michelle, et al.
Publicado: (2016)

LAPTM4B is associated with poor prognosis in NSCLC and promotes the NRF2-mediated stress response pathway in lung cancer cells
por: Maki, Yuho, et al.
Publicado: (2015)

LAPTM4B‐35 promotes cancer cell migration via stimulating integrin beta1 recycling and focal adhesion dynamics
por: Liu, Minxia, et al.
Publicado: (2022)

Overexpressed LAPTM4B-35 is a risk factor for cancer recurrence and poor prognosis in non-small-cell lung cancer
por: Kong, Fanming, et al.
Publicado: (2016)

LAPTM4B is a novel diagnostic and prognostic marker for lung adenocarcinoma and associated with mutant EGFR
por: Wang, Lu, et al.
Publicado: (2019)

The relationship between LAPTM4B polymorphisms and cancer risk in Chinese Han population: a meta-analysis
por: Xia, Ling-Zi, et al.
Publicado: (2015)

Relationship between LAPTM4B Gene Polymorphism and Prognosis of Patients following Tumor Resection for Colorectal and Esophageal Cancers
por: Cheng, Xiaojing, et al.
Publicado: (2016)

Association between LAPTM4B gene polymorphism and susceptibility to and prognosis of diffuse large B-cell lymphoma
por: Ding, Huirong, et al.
Publicado: (2018)

LAPTM4b recruits the LAT1-4F2hc Leu transporter to lysosomes and promotes mTORC1 activation
por: Milkereit, Ruth, et al.
Publicado: (2015)

LAPTM4B Allele *2 Is a Marker of Poor Prognosis Following Hepatic Tumor Resection for Hepatocellular Carcinoma
por: Yang, Hua, et al.
Publicado: (2012)

miR-188-5p inhibits tumour growth and metastasis in prostate cancer by repressing LAPTM4B expression
por: Zhang, Hongtuan, et al.
Publicado: (2015)

A Role for the Ubiquitin Ligase Nedd4 in Membrane Sorting of LAPTM4 Proteins
por: Milkereit, Ruth, et al.
Publicado: (2011)

Co-expression of HIF-1α, MDR1 and LAPTM4B in peripheral blood of solid tumors
por: Rehman, Zaira, et al.
Publicado: (2019)

Overexpression of LAPTM4B-35 is a negative prognostic factor in head and neck squamous cell carcinoma
por: Kotowski, Ulana, et al.
Publicado: (2019)

LAPTM4B-35 expression is associated with pathological grades and clinical stages in salivary adenoid cystic carcinoma
por: Fan, Jianlin, et al.
Publicado: (2020)

Long Noncoding RNA HCAL Facilitates the Growth and Metastasis of Hepatocellular Carcinoma by Acting as a ceRNA of LAPTM4B
por: Xie, Cheng-Rong, et al.
Publicado: (2017)

Long Non-Coding RNA TP73-AS1 Promotes the Development of Lung Cancer by Targeting the miR-27b-3p/LAPTM4B Axis
por: Jiang, Qingfeng, et al.
Publicado: (2020)

LAPTM4B-35, a Cancer-Related Gene, Is Associated with Poor Prognosis in TNM Stages I-III Gastric Cancer Patients
por: Cheng, Xiaojing, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2umm5vvnsr8p07sds7fakgpau9